相关实验视频
Updated: Jul 17, 2025

09:10
Synthesis of Indoxyl-glycosides for Detection of Glycosidase Activities
Published on: May 27, 2015
6.7K
一个研究含有1,2,4-triazole的酸和盐的低血糖活性
概括
研究人员研究了1,2,4-三醇衍生物的降低血糖的能力. (II) 2-{5-[(3,4-甲基) - 3H-1,2,4-三-3-yl]thio}乙酸显示出显著的低血糖活性,降低了27.3%的血糖.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 越来越多的久坐不动的生活方式和高含糖食物的饮食,需要新的低血糖药物.
- 开发有效和低毒性药物来控制血糖水平是医学和制药界的一个关键目标.
研究的目的:
- 合成和评估新型1,2,4-三衍生物的低血糖特性.
- 识别具有显著降低血糖潜力的化合物.
主要方法:
- 1,2,4-三醇衍生物的合成.
- 合成化合物的急性毒性预测.
- 在大鼠中使用腹腔内葡萄糖耐受性测试 (IPGTT) 评估低血糖活性.
- 用药剂量为每公斤体重2g的化合物.
主要成果:
- 对38种不同类型的化合物进行了低血糖活性选.
- (II) 2-{5-[(3,4-甲基) - 3H-1,2,4-三-3-yl]thio}乙酸盐 (化合物3.18) 显示出最强效的作用.
- 与对照组相比,化合物3.18降低了27.3% (约1.3倍) 的血糖水平.
结论:
- 合成的1,2,4-三衍生物显示出作为潜在的低血糖剂的前景.
- 化合物3.18是管理高血糖症的进一步开发的主要候选物.
更多相关视频
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
205
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
205
Oral Hypoglycemic Agents: Sulfonylureas
236
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
236
Oral Hypoglycemic Agents: Glinides
184
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
184
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230
Diazonium Group Substitution: –OH and –H
2.8K
Nitrous acid, a weak acid, is prepared in situ via the reaction of sodium nitrite with a strong acid under cold conditions. This nitrous acid prepared in situ reacts with primary arylamines to form arenediazonium salts. Such reactions are known as diazotization reactions. As shown in Figure 1, the formation of arenediazonium salts begins with the decomposition of nitrous acid in an acidic solution to give nitrosonium ions.
2.8K
Antihypertensive Drugs: Thiazide-Class Diuretics
738
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
738

